SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-070249
Filing Date
2024-08-16
Accepted
2024-08-16 16:15:32
Documents
6
Effectiveness Date
2024-08-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0211015-s8_hoththerap.htm S-8 45804
2 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea021101501ex5-1_hoththerap.htm EX-5.1 10812
3 AMENDMENT NO. 1 TO HOTH THERAPEUTICS, INC. AMENDED AND RESTATED 2022 OMNIBUS EQU ea021101501ex10-2_hoththerap.htm EX-10.2 5587
4 CONSENT OF WITHUMSMITH+BROWN, PC ea021101501ex23-1_hoththerap.htm EX-23.1 1902
5 FILING FEE TABLE ea021101501ex-fee_hoththerap.htm EX-FILING FEES 23997
6 GRAPHIC ex5-1_001.jpg GRAPHIC 2825
  Complete submission text file 0001213900-24-070249.txt   93193
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281610 | Film No.: 241216899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)